Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
NEW YORK, June 25 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading on Safety First Trust Series 2008-2's Principal-Protected Trust Certificates Linked to the S&P 500...
AMS Health Sciences, Inc., (AMEX:AMM), today announced a net?loss for the first quarter 2007 of ($410,339), or ($0.05) per common (diluted) share, on 8.5 million shares...
AMS Health Sciences, Inc., (AMEX: AMM), announces its first quarter earnings will be released Friday, May 11, 2007. The AMS first quarter earnings conference call will be held:...
Dr. Jerry Grizzle, Chairman of the Board, President and Chief Executive Officer for AMS Health Sciences (AMEX: AMM), a leading direct selling company, announces the launch of...
AMS Health Sciences, Inc. (AMEX:AMM) announced today the appointment of Lawrence R. Moreau to the Board of Directors. Mr. Moreau was appointed by unanimous written consent. Mr...
AMS Health Sciences, Inc (AMEX:AMM) announced today the nomination and election of Richard C. Wiser to the Board of Directors. Mr. Wiser was elected by unanimous written...
AMS Health Sciences, Inc. (AMEX:AMM) announced the execution of certain lease and purchase agreements between Heartland Cup Inc. and Republic Plastics Ltd. (collectively, the...
AMS Health Sciences, Inc., (Amex: AMM), today announced a net?loss from continuing operations for the third quarter 2006 of $583,299, or $0.07 per common share, on 7.8 million...
AMS Health Sciences, Inc., (AMEX: AMM - News), will release 2006 third quarter results on Tuesday, November 14, 2006. The Company will host a conference call to discuss these...
AMS Health Sciences, Inc. (AMEX:AMM) today announced that it will be exhibiting and presenting at the ValueRich Small-Cap Financial Expo at the Wynn Las Vegas Resort. Dr...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
